Andrew Kenneth William Powell
CIK 1304113 · SVP, General Counsel & Crp Sec · last filed 2024-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$144.8K
Companies
8
Total Filings
58
Lifetime Open-Market Net
-$203.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRS | Director | 33,523 | $4.32 | $144.8K | $27.5K | 14 | 2024-06-04 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Director | — | $5.87 | — | $0 | 3 | 2022-06-13 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Director | 27,477 | $8.76 | $240.7K | $6.1K | 11 | 2022-06-07 |
| Synthorx, Inc. (THOR) Delisted | Director | — | — | — | $0 | 3 | 2020-01-24 |
| MEDIVATION, INC. (MDVN) Delisted | SVP, General Counsel & Crp Sec | 28,517 | — | — | -$155.8K | 5 | 2016-06-06 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | EVP, General Counsel | 89,785 | $1.95 | $175.1K | -$91.4K | 10 | 2013-08-30 |
| IMCLONE SYSTEMS INC (IMCL) Delisted | SVP and General Counsel | — | — | — | $0 | 1 | 2008-08-12 |
| COLLAGENEX PHARMACEUTICALS INC (CGPI) Delisted | VP, G. Counsel and Corp. Sec. | 7,500 | — | — | $10.6K | 5 | 2007-11-30 |
Recent Filings · Page 2 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-08 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | ACRS | Grant (A) | — | $0 | EDGAR |
| 2021-06-03 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Mixed | +8,303 | $96.6K | EDGAR |
| 2020-12-07 | ARS Pharmaceuticals, Inc. (SBTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-19 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Mixed | +2,200 | $22.8K | EDGAR |
| 2020-06-08 | ACRS | Mixed | +7,333 | $0 | EDGAR |
| 2020-06-02 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-29 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Mixed | +6,000 | $65.9K | EDGAR |
| 2020-03-04 | ACRS | Mixed | +8,876 | $0 | EDGAR |
| 2020-01-24 | Synthorx, Inc. (THOR) Delisted | Disp (D) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.